Shefflette A, Patel N, Caruso J
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults with Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA 325(14):14141425
"What fundamentally differentiates Calibrate from anyone else on the internet is that we really believe that to increase access to obesity treatment, you have to find a way to use GLP-1s across a population cost effectively, which means some people are on and off of them
We express our gratitude to Pengfei Gong, Ruipei Ouyang, and Yongjie Shi from Jiangsu Province Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation, China Pharmaceutical University , for helping revise the manuscript
I made a practical guide on GLP-1 weight loss and muscle preservation, and Im giving it away free